ProFibrix BV, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has raised $11 million in Series A funding led by Index Ventures. www.profibrix.com
ProFibrix BV, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has raised $11 million in Series A funding led by Index Ventures. www.profibrix.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
